Bimekizumab in psoriatic arthritis: a great leap forward?

Lancet. 2023 Jan 7;401(10370):2-3. doi: 10.1016/S0140-6736(22)02423-0. Epub 2022 Dec 6.

Author

Rubén Queiro¹

Affiliation

¹ Rheumatology Division, Hospital Universitario Central de Asturias, Oviedo 33011, Spain; Division of Translational Immunology, Health Research Institute of the Principality of Asturias, Oviedo, Spain; Faculty of Medicine, Oviedo University, Oviedo, Spain. Electronic address: rubenque7@yahoo.es.

PMID: 36495880
DOI: 10.1016/S0140-6736(22)02423-0

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Arthritis, Psoriatic* / drug therapy
Humans
Psoriasis*

Substances

bimekizumab
Antibodies, Monoclonal, Humanized